Press Releases

DEERFIELD, Ill.--(BUSINESS WIRE)-- Walgreens today announced that it has launched a new program called Feel More Like You™, developed to help people living with cancer and their caregivers manage the potential physical changes associated with cancer treatment. The exclusive offering will be available at more than 400 Walgreens stores in select markets across the country. This

NEW YORK--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (Nasdaq:RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, to

ATLANTA--(BUSINESS WIRE)-- EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed a strategic partnership with Georgia Eye Associates, expanding its presence into the Lawrenceville and northeast Atlanta regions. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower middle market healthcare p

BURLINGTON, Mass. & OXFORD, England--(BUSINESS WIRE)-- Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced results from an investigational Phase 3 blinded image evaluation (BIE) study of the diagnostic efficacy of 18F-fluciclovine positron emission tomography (PET) imaging, as an adjunct to magnetic resonance imaging (MRI), in adults with glioma. The primary aim was to

BASEL, Switzerland & IRVINE, Calif.--(BUSINESS WIRE)-- Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing novel therapies for urologic conditions, today announced Chief Executive Officer Keith A. Katkin is scheduled to participate in the Piper Jaffray Healthcare Conference on Tuesday, November 27, 2018 at 4:30 p.m. ET in New York City.

CRANBURY, N.J.--(BUSINESS WIRE)-- The Board of Directors of Innophos Holdings, Inc. (NASDAQ:IPHS), a leading international producer of specialty ingredient solutions for the food, health, nutrition and industrial markets, announced the appointment of Jane Hilk as a Director effective today. Ms. Hilk has over three decades of experience in executive positions within the food and beverage industry. Mos

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target immune drivers of cancer and other immune-related disorders, today announced that Brian Wong, M.D., Ph.D., CEO and Rekha Hemrajani, COO will participate in an analyst-led fireside chat at the Evercore ISI HealthCONx on Tuesday, November 27

DUNKIRK, Md.--(BUSINESS WIRE)-- PATRIOT is pleased to announce that it has received conditional approval from the Calvert County Planning Commission to construct its new global headquarters. PATRIOT currently leases multiple spaces in Dunkirk, but has outgrown its current location. Rather than relocate the company to a neighboring jurisdiction, PATRIOT chose to keep the company headquartered in Dunkirk due to t

PORTLAND, Ore.--(BUSINESS WIRE)-- Today, NuScale Power announced that it has selected Minnesota-based PaR Systems, LLC to begin engineering work for the manufacturing of its Reactor Building Crane (RBC), an important element of NuScale’s innovative nuclear plant design. The decision follows an intensive selection process involving several major U.S. nuclear crane suppliers. NuScale selected the best compa

DUARTE, Calif.--(BUSINESS WIRE)-- City of Hope announced today that it will present data on new findings on immunotherapies, including CAR T cell therapy, bone marrow transplants and other treatments for blood cancers, at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4 in San Diego. City of Hope is addressing some of the hardest-to-treat cancers by accelerating innovative clinical re

ARLINGTON, Va.--(BUSINESS WIRE)-- CACI International Inc (NYSE: CACI) announced today that it has been awarded a $413 million prime contract by the General Servi

MADISON, Wis.--(BUSINESS WIRE)-- Navitus Health Solutions today announced that Lumicera Health Services, its wholly owned specialty pharmacy, has entered into a strategic agreement with ParcelShield, a predictive parcel science company, to enhance specialty medication delivery to patients who suffer from chronic conditions. Lumicera provides specialty medications and personalized clinical supp

MORRISVILLE, N.C.--(BUSINESS WIRE)-- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that Stanford University School of Medicine has been activated as the first clinical research site for the Company’s Phase 2 trial designed to evaluate levosimendan in patients with pul

EXCHANGE PLACE, N.J.--(BUSINESS WIRE)-- Top-tier online bookmaker PointsBet today announced it has entered into an exclusive multi-year partnership with card solutions provider

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- QurAlis Corporation, a biotech company focused on developing precision therapeutics for ALS and other neurological diseases, today announc